ACME Lab MD to raise his stakes

Mizanur Rahman Sinha, the managing director of ACME Laboratories,has announced his intention to raise his stake, in what can be viewed as an endorsement of the pharmaceutical company’s prospects.

Sinha, who is also one of the sponsor-directors, is set to buy 131,000 shares of ACME Laboratories at the prevailing market price within the next 30 working days.

The sponsor-director currently holds 17,245,119 shares, which is 8.15 per cent of the stakes of the 66-year-old pharmaceutical company.

Earlier in September this year, he gifted his 3,516,446 shares of ACME Laboratories to his daughter Tasneem Sinha, another director.

The news of Sinha’s stake purchase helped the stock to close 1.47per cent higher at Tk 76.1 on Monday.

ACME Laboratories posted a profit of Tk 145 crore in its 2019-2020 financial year, up 0.7 per cent from a year earlier.

In the first three months of its 2020-21 financial year, it logged in a profit of Tk 41.5 crore, up 3.7 per cent year-on-year.

As of last month, sponsors and directors jointly hold 41.6 per centof the company, which was listed with the exchanges in 2016.